Synthase Biotech raises $800,000 to develop plant-based enzyme that stops fats going rancid

Synthase Biotech raises $800,000 to develop plant-based enzyme that stops fats going rancid
Fiona Rotherham
By Fiona Rotherham Dec. 5 (BusinessDesk) - Synthase Biotech, set up last year to commercialise a plant-based enzyme that stops fats going rancid, has raised $800,000 in its first external capital raising. The Waikato-based company is initially targeting artificial insemination for the global dairy industry. Its trademarked enzyme Aloxsyn has been shown to extend the life of fresh and frozen sperm, improving the ability of cows to conceive. Aloxsyn is a platform technology and the startup also plans to apply it to beef cattle, pigs, and...